RshA mutations contributing to tigecycline resistance in Mycobacteroides abscessus

References

1. Howard ST, Byrd TF, Lyons CR. A polymorphic region in Mycobacterium abscessus contains a novel insertion sequence element. Microbiology (Reading) 2002; 148:2987–2996 [View Article] [PubMed]
   [Google Scholar]
2. Ryan K, Byrd TF. Mycobacterium abscessus: Shapeshifter of the Mycobacterial World. Front Microbiol 2018; 9:2642 [View Article] [PubMed]
   [Google Scholar]
3. Lee M-R, Sheng W-H, Hung C-C, Yu C-J, Lee L-N et al. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis 2015; 21:1638–1646 [View Article] [PubMed]
   [Google Scholar]
4. Sfeir M, Walsh M, Rosa R, Aragon L, Liu SY et al. Mycobacterium abscessus complex infections: a retrospective cohort study. Open Forum Infect Dis 2018; 5:ofy022 [View Article] [PubMed]
   [Google Scholar]
5. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD et al. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011; 52:565–571 [View Article] [PubMed]
   [Google Scholar]
6. Wallace RJ Jr, Dukart G, Brown-Elliott BA, Griffith DE, Scerpella EG et al. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother 2014; 69:1945–1953 [View Article] [PubMed]
   [Google Scholar]
7. Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D et al. Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease. Antimicrob Agents Chemother 2016; 60:2895–2900 [View Article] [PubMed]
   [Google Scholar]
8. Ananta P, Kham-Ngam I, Chetchotisakd P, Chaimanee P, Reechaipichitkul W et al. Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand. PLoS ONE 2018; 13:1–15 [View Article] [PubMed]
   [Google Scholar]
9. Ng HF, Tan JL, Zin T, Yap SF, Ngeow YF. A mutation in anti-sigma factor MAB_3542c may be responsible for tigecycline resistance in Mycobacterium abscessus. J Med Microbiol 2018; 67:1676–1681 [View Article] [PubMed]
   [Google Scholar]
10. Lee CL, Ng HF, Ngeow YF, Thaw Z. A stop–gain mutation in sigma factor SigH (MAB_3543c) may be associated with tigecycline resistance in Mycobacteroides abscessus. J Med Microbiol 2021; 70: [View Article]
    [Google Scholar]
11. Song T, Dove SL, Lee KH, Husson RN. RshA, an anti-sigma factor that regulates the activity of the mycobacterial stress response sigma factor SigH. Mol Microbiol 2003; 50:949–959 [View Article] [PubMed]
    [Google Scholar]
12. Ng HF, Ngeow YF, Yap SF, Zin T, Tan JL. Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus. Int J Med Microbiol 2020; 310:151380 [View Article] [PubMed]
    [Google Scholar]
13. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45 [View Article] [PubMed]
    [Google Scholar]
14. Ng HF, Ngeow YF. A simple spreadsheet-based method for relative quantification using quantitative real-time PCR. Biochem Mol Biol Educ 2022; 50:99–103 [View Article] [PubMed]
    [Google Scholar]
15. Woods EC, McBride SM. Regulation of antimicrobial resistance by extracytoplasmic function (ECF) sigma factors. Microbes Infect 2017; 19:238–248 [View Article] [PubMed]
    [Google Scholar]